SOURCE: Hard to Treat Diseases, Inc.

December 07, 2006 08:00 ET

Hard To Treat Diseases, Incorporated Announces: Oral Argument and Stock Dividend Update

DELRAY BEACH, FL -- (MARKET WIRE) -- December 7, 2006 -- Hard To Treat Diseases, Incorporated (HTTD) (PINKSHEETS: HTDS) announces that the Company presented its oral argument to the Eleventh Circuit of the U.S. Court of Appeals on December 6, 2006.

Counsel for both sides in the case of HTTD vs. Shinn, Knight and Shinn Capital Group presented oral argument to the Eleventh Circuit yesterday. The panel of Appellate Judges is well-versed on the issues being appealed. The Court's ruling will be available as soon as it is released.

HTTD shareholders of record as of June 13, 2006 have received their Cavit Sciences, Inc. ("Cavit") stock dividend. If you have not received your shares, please contact HTTD at the fax number or email address listed below. Cavit information is available at

HTTD's website and corporate overview are being updated to reflect the Cavit transaction, its divisions and the ongoing litigation to secure our assets from prior officers and directors with the assistance of regulatory agencies.

Additional information is available on the Company's website at:

Cautionary Note Regarding Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this news release may contain or constitute forward-looking statements. These forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions of the Private Securities Litigation Act of 1995, Hard to Treat Diseases, Inc. provides the following cautionary statement identifying important factors which, among others, could cause the actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Contact Information